Two distinct P70 interleukin-2 receptors on a murine large granular lymphocyte clone Y479

H Takemoto1, H Yagi, M Harada

  • 1Shionogi Research Laboratories, Shionogi & Co., Ltd., Osaka, Japan.

Insights

Researchers identified two distinct 70 kDa interleukin-2 receptors (IL-2R) on mouse Y479 cells. These receptors bind IL-2 despite lacking the typical p55 IL-2R subunit, offering new insights into IL-2 signaling.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Interleukin-2 (IL-2) is crucial for T cell proliferation and function.
  • IL-2 signaling is primarily mediated by the IL-2 receptor (IL-2R), composed of alpha (CD25, p55), beta (p70-75), and gamma (p64) subunits.
  • Understanding IL-2R heterogeneity is vital for deciphering immune responses.

Purpose of the Study:

  • To characterize the IL-2 binding proteins on the Y479 cloned cell line.
  • To investigate the structure and epitopes of IL-2 receptors on Y479 cells.
  • To determine if Y479 cells express the canonical p55 IL-2R subunit.

Main Methods:

  • Establishment of a continuous cloned cell line (Y479) from mouse spleen cells cultured in high IL-2.
  • Phenotypic analysis of Y479 cells using flow cytometry.
  • IL-2 binding assays and immunoprecipitation using radioiodinated IL-2 and monoclonal antibodies against human IL-2.
  • Limited trypsin digestion of IL-2-cross-linked cells.

Main Results:

  • Y479 cells, a large granular lymphocyte line, expressed IL-2 binding proteins but lacked detectable p55 IL-2R.
  • Both high and low affinity IL-2 binding were mediated by a 70 kDa protein.
  • Monoclonal antibodies recognized different epitopes on the 70 kDa IL-2R.
  • Trypsin digestion yielded a 45 kDa fragment, suggesting distinct structural domains within the 70 kDa IL-2R.

Conclusions:

  • Y479 cells possess at least two distinct types of 70 kDa IL-2 receptors.
  • These receptors mediate IL-2 binding independently of the p55 IL-2R subunit.
  • The findings reveal novel IL-2 receptor heterogeneity and potential alternative IL-2 signaling pathways.